Clinical indicators of occult musculoskeletal pain in aggressive dogs

AGGRESSIVE behaviour by dogs is the most frequent behaviour problem reported to veterinary behaviour clinics (Bamberger and Houpt 2006, Fatjo and others 2007). The behaviour is a serious problem for the victims (Weiss and others 1998) and for the animals themselves, since it often reflects a negative underlying emotional state, especially if associated with pain (Bamberger and Houpt 2006, Hsu and Sun 2010). Pain may lower the dog’s general threshold for aggressive behaviour, while also encouraging specific aggressive displays as part of a protective/defensive response (Rutherford 2002, Muir and others 2004, Landsberg and others 2013). Beaver (1983) has suggested that more than a quarter (28.2 per cent) of dogs exhibiting aggression do so because of a medical condition, including pain, but pain-related aggression has been considered to account for only a small per cent of the total caseload in behaviour clinics, that is, 2–3.3 per cent (Beaver 1983, Borchelt 1983). However, when pain is identi- fied, the data from Beaver (1983) suggest the prognosis is excellent, with all cases in her case review reported to have a successful treatment outcome. A recent small case series of aggressive dogs with a pain focus indicated that musculoskeletal pain from hip dysplasia and osteoarthritis of the elbow was the main cause of pain, occurring in 75 per cent (nine of 12 cases) of these cases (Camps and others 2012)

Behavioural and Physiological Correlates of the Canine Frustration Questionnaire

Frustration is a negative emotional state implicated in a range of canine behaviour problems. The Canine Frustration Questionnaire (CFQ) is the first psychometric tool developed to assess frustration tendencies in dogs based on owner report. However, to date, no published studies have assessed behavioural and physiological correlates of this trait. A novel behaviour test battery was developed to induce frustration in dogs, mapping onto the CFQ. Forty-four dogs were recruited and filmed whilst undertaking the test battery, and a CFQ was completed by each owner. Targeted behavioural measures were assessed from this footage, based on hypotheses aimed at evaluating convergent and discriminant validity with facets of the CFQ. In addition, a saliva sample was collected pre- and post-testing for 39 dogs, and a cortisol assay performed using ELISA to provide a physiological measure of arousal. A range of predicted behavioural test measures (e.g., vocalising and lunging) positively correlated with CFQ scores. For 22 dogs with pre-test salivary cortisol levels of <4 ng/mL (indicative of normal arousal at baseline), cortisol change and post-test cortisol levels positively correlated with the CFQ PC5 ‘Frustration coping’ score. These results provide further evidence of the validity of frustration tendencies as measured by owner report through the CFQ

The Canine Frustration Questionnaire—Development of a New Psychometric Tool for Measuring Frustration in Domestic Dogs (Canis familiaris)

Introduction: Psychometric tools have been developed for the assessment of behavioral and affective traits in non-human animals. Frustration can be defined as an emotional reaction experienced after a given expectation is violated. Frustration is a negative emotional state and whilst it probably plays a key role in certain behavior problems in dogs (e.g., aggressive behaviors), there appears to have been little attempt to scale this affective tendency. Therefore, the aim of the current study was to develop a tool to assess frustration tendencies in dogs. Materials and Methods: An online owner survey was developed. Items covered demographics, the training/behavioral history of the dog, and 33 frustration related items scored using a 5-point Likert scale. The questionnaire was disseminated via on-line channels over a 5-month period. Two thousand three hundred forty-eight respondents completed the questionnaire. Of these, 273 respondents completed it a second time 6 weeks later, and a separate 276 respondents completed it a second time 1 year later. Additionally, 92 paired responses were collected where two carers completed the questionnaire independently about the same dog. Intra- and inter-rater reliabilities were assessed prior to structuring the items using principal component analysis (PCA) with a Varimax rotation. Items were retained if they loaded > 0.4 on at least one of the components extracted using the Kaiser criterion. Results: Twenty-two items were deemed to be reliable enough to be used in the PCA and 21 items loaded on a biologically meaningful 5-principal component solution. There was a significant positive correlation between each principal component and the owners' general perception of their dogs' frustration tendencies, alongside other expected correlates. Conclusion: This is the first reliable psychometric tool for the assessment of frustration in dogs—the Canine Frustration Questionnaire (CFQ). Further validation with behavioral tests and physiological measures is ongoing

Emotional affect and the occurrence of owner reported health problems in the domestic dog

Interactions between health, behaviour and individual differences such as; mood, affect or personality have been studied more in humans than they have in non-human animals. In humans, links can be made between personality and the expression of health problems, and between personality, affect, coping, treatment and recovery success. Previous research with animals has shown that personality and mood interact to determine judgement bias and that personality interacts with stress responses and pain expression. This indicates that the way animals deal with life events is dependent on interactions between personality and mood and that pain behaviours observed in animals are not always reflective of disease severity. As such, reliance only on behavioural displays of pain in health assessments, without information on what may mediate or moderate that behaviour makes accurate treatment difficult. The aim of this study was to look at the interactions between the occurrence of health conditions in pet dogs (as reported by their owner), behaviour and the dogs’ score on core (positive and negative) affect. A survey collected information from dog owners about their dog’s breed, sex, age, past and current medical record, occurrence of behaviour, and their dog’s level of positive and negative affect. Nine hundred and forty-three responses were obtained, of which 796 were used in the analysis. Binomial logistic regressions were conducted, with either current or previous experience of a range of general health and pain-causing conditions included as dependent variables, and affectivity domains, aggression and age as independent variables. For most of the general health conditions (with the exception of the dental, vision and hearing problem category), only age was a predictor of both current and previous experience of a health condition. However, positive affect was associated with current experience of a pain-causing condition, with lower positive affect scores being most associated with presence of a current pain-causing condition. Only age was associated with experience of a previous condition. Finally, no difference in aggression scores was observed between dogs in any of the pain experience categories. These results provide novel findings for an association between health problems and affect in dogs

Primary cerebellar glioblastoma multiforme

Glioblastoma multiforme in adults arising in the cerebellum is a rare tumor, well documented in only 13 cases in the literature. We report a fourteenth case, an 80-year-old female, and reassess the clinical and CT aspects of this tumor based on a review of the world's literature. The median age of patients is 53 years with a median survival of three months, which is less than adult cerebral hemisphere malignant gliomas.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/45390/1/11060_2004_Article_BF00151226.pd

Products of cells from gliomas: IX. Evidence that two fundamentally different mechanisms change extracellular matrix expression by gliomas

Four human astrocytic gliomas of high grade of malignancy were each evaluated in tissue and in vitro for percentages of cells expressing glial fibrillary acidic protein (GFAP), collagen type IV, laminin and fibronectin assessed by immunofluorescence with counterstaining of nuclear DNA. Percentages of cells with reticulin and cells binding fluorescein-labeled Ulex europaeus agglutinin were also assessed. In tissue, each extracellular matrix (ECM) component was associated with cells in the walls of abnormal proliferations of glioma vessels, and all four tumors had the same staining pattern. Two strikingly different patterns of conversion of gene product expression emerged during in vitro cultivation. (1). In the most common pattern, percentages of all six markers consistently shifted toward the exact phenotype of mesenchymal cells in abnormal vascular proliferations: increased reticulin, collagen type IV, laminin and fibronectin; markedly decreased glial marker GFAP and absent endothelial marker Ulex europaeus agglutinin. The simplest explanation of this constellation of changes coordinated toward expression of vascular ECM markers is that primary glioma cell cultures are overgrown by mesenchymal cells from the abnormal vascular proliferations of the original glioma. These cell cultures were tested for in situ hybridization (ISH) signals of chromosomes 7 and 10. Cells from one glioma had diploid signals. Cells from the other glioma had aneuploid signals indicating they were neoplastic; however, their signals reflected different numerical chromosomal aberrations than those common to neoplastic glia. (2). The second pattern was different. Cells with ISH chromosomal signals of neoplastic glia retained GFAP, and gained collagen type IV. Their laminin and fibronectin diminished, but persisted among a lower percentage of cells. Cloning and double immunofluorescence confirmed the presence of individual cells with glial and mesenchymal markers. A cell expressing GFAP in addition to either fibronectin, reticulin or collagen type IV is not a known constituent of glioblastoma tissue. This provides evidence of a second mechanism of conversion of gene expression in gliomas.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/45382/1/11060_2005_Article_BF01052843.pd